Jean-Yves Blay
Department of Medical Oncology
Centre Léon Bérard
France
Name/email consistency: high
- Updating progress in sarcoma therapy with mTOR inhibitors. Blay, J.Y. Ann. Oncol. (2011)
- Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib. Blay, J.Y. Ann. Oncol. (2010)
- Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Blay, J.Y., von Mehren, M., Blackstein, M.E. Cancer (2010)
- Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour? Blay, J.Y., Adenis, A., Ray-Coquard, I., Cassier, P.A., Le Cesne, A. Curr. Opin. Oncol (2009)
- Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations. Blay, J.Y., Reichardt, P. Expert. Rev. Anticancer. Ther (2009)
- New paradigms in gastrointestinal stromal tumour management. Blay, J.Y. Ann. Oncol. (2009)
- Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Blay, J.Y., Le Cesne, A. Oncologist (2009)
- Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma. Blay, J.Y., von Mehren, M., Samuels, B.L., Fanucchi, M.P., Ray-Coquard, I., Buckley, B., Gilles, L., Lebedinsky, C., Elsayed, Y.A., Le Cesne, A. Clin. Cancer Res. (2008)
- Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. Blay, J.Y., Le Cesne, A., Ray-Coquard, I., Bui, B., Duffaud, F., Delbaldo, C., Adenis, A., Viens, P., Rios, M., Bompas, E., Cupissol, D., Guillemet, C., Kerbrat, P., Fayette, J., Chabaud, S., Berthaud, P., Perol, D. J. Clin. Oncol. (2007)
- Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE). Blay, J.Y., Koscielny, S., Trédaniel, J., Asselain, B., Goldwasser, F., Misset, J.L., de Labareyre, C., Hagège, C., Bismut, H., Marty, M. Crit. Rev. Oncol. Hematol. (2007)
- Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Blay, J.Y., Bonvalot, S., Casali, P., Choi, H., Debiec-Richter, M., Dei Tos, A.P., Emile, J.F., Gronchi, A., Hogendoorn, P.C., Joensuu, H., Le Cesne, A., McClure, J., Mac Clure, J., Maurel, J., Nupponen, N., Ray-Coquard, I., Reichardt, P., Sciot, R., Stroobants, S., van Glabbeke, M., van Oosterom, A., Demetri, G.D. Ann. Oncol. (2005)
- Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. Blay, J.Y., van Glabbeke, M., Verweij, J., van Oosterom, A.T., Le Cesne, A., Oosterhuis, J.W., Judson, I., Nielsen, O.S. Eur. J. Cancer (2003)
- Primary cerebral lymphomas: unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses. The FNCLCC. French Fédération Nationale des Centres de Lutte contre le Cancer. Blay, J.Y., Ongolo-Zogo, P., Sebban, C., Carrie, C., Thiesse, P., Biron, P. Ann. Oncol. (2000)
- High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. Blay, J.Y., Bouhour, D., Ray-Coquard, I., Dumontet, C., Philip, T., Biron, P. J. Clin. Oncol. (2000)
- Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens. Blay, J.Y., Judson, I., Rodenhuis, S., Hermans, C., Smith, M., van Glabbeke, M., Verweij, J. Anticancer. Drugs (1999)
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. Blay, J.Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N., Eghbali, H., Bouabdallah, R., Coiffier, B., Wagner, J.P., Le Mevel, A., Dramais-Marcel, D., Baumelou, E., Chauvin, F., Biron, P. J. Clin. Oncol. (1998)
- A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy. Blay, J.Y., Le Cesne, A., Mermet, C., Maugard, C., Ravaud, A., Chevreau, C., Sebban, C., Guastalla, J., Biron, P., Ray-Coquard, I. Blood (1998)
- The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group. Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., Hagenbeek, A., Somers, R., Chauvin, F., Philip, T. Blood (1998)
- Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Blay, J.Y., Rossi, J.F., Wijdenes, J., Menetrier-Caux, C., Schemann, S., Négrier, S., Philip, T., Favrot, M. Int. J. Cancer (1997)